Associations between Systemic Markers of Bone Turnover or Bone Mineral Density and Anti-Resorptive Agent-Related Osteonecrosis of the Jaw in Patients Treated with Anti-Resorptive Agents.

about

Associations between Systemic Markers of Bone Turnover or Bone Mineral Density and Anti-Resorptive Agent-Related Osteonecrosis of the Jaw in Patients Treated with Anti-Resorptive Agents.

Item

http://www.wikidata.org/entity/Q36753894

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Associations between Systemic ...... d with Anti-Resorptive Agents.

@en

type

Item

label

Associations between Systemic ...... d with Anti-Resorptive Agents.

@en

prefLabel

Associations between Systemic ...... d with Anti-Resorptive Agents.

@en

P1476

Associations between Systemic ...... d with Anti-Resorptive Agents.

@en

P2093

Isamu Kodani

http://www.w3.org/2001/XMLSchema#string

Kazuhito Tohashi

http://www.w3.org/2001/XMLSchema#string

Kazunori Kidani

http://www.w3.org/2001/XMLSchema#string

Kazuo Ryoke

http://www.w3.org/2001/XMLSchema#string

Motoki Nakabayashi

http://www.w3.org/2001/XMLSchema#string

P2860

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

Bisphosphonates and osteonecrosis of the jaw

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials

Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.

A pilot case-control study on the alveolar bone density measurement in risk assessment for bisphosphonate-related osteonecrosis of the jaw.

Osteonecrosis of the jaw in a patient on Denosumab.

Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.

American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.

Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats.

P304

45-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27046950

http://www.w3.org/2001/XMLSchema#string

P932

4816748

http://www.w3.org/2001/XMLSchema#string